2m 2m 2m 2m 2m 2m 2m
COGNITION THERAP (CGTX)
NASDAQ
$1.43+$0.005 (+0.35%)
Price as of Jun 03, 2026 7:57 PM EDT- $105.6MMarket Cap
- 335.62%1-Year Change
- BiotechnologyIndustry
COGNITION THERAP (CGTX)
$1.43+$0.005 (+0.35%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | -27,000 -3.57% | -28,000 -96.86% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 +100.00% | -27,000 -3.57% | -28,000 -96.86% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -37.2M -10.77% | -41.7M +12.04% | -37.2M +22.66% | -30.3M +63.28% | |
Depreciation and Amortization Expense | 36,000 -66.36% | 107,000 +11.46% | 96,000 +15.66% | 83,000 -10.75% | |
Total Operating Expenses | 47.8M -11.43% | 54.0M +6.39% | 50.7M +16.47% | 43.6M +52.29% | |
Operating Profit | -47.8M -11.43% | -54.0M +6.39% | -50.7M +16.47% | -43.6M +52.29% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -13,000 -48.00% | -25,000 -7.41% | -27,000 -3.57% | -28,000 -96.86% | |
Interest Income and Expense and Net | -13,000 -48.00% | -25,000 -7.41% | -27,000 -3.57% | -28,000 -96.86% | |
Total Nonoperating Income and Expense | 24.3M +21.59% | 20.0M -19.81% | 24.9M +12.56% | 22.2M +31.23% | |
Income before Taxes | -47.8M -11.43% | -54.0M +6.39% | -50.7M +137.06% | -21.4M +31.69% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -23.5M -30.86% | -34.0M +31.73% | -25.8M +20.52% | -21.4M +82.63% | |
Net Income from Continuing Operations Applicable to Common | -23.5M -30.86% | -34.0M +31.73% | -25.8M +20.52% | -21.4M +31.69% | |
Basic EPS and Net Income | -0.32 -62.79% | -0.86 0.00% | -0.86 -5.49% | -0.91 -70.93% | |
Diluted EPS and Net Income | -0.32 -62.79% | -0.86 0.00% | -0.86 -5.49% | -0.91 -70.93% | |
Basic Weighted Average Shares | 72.8M +83.15% | 39.7M +32.31% | 30.0M +27.03% | 23.6M +355.42% | |
Diluted Weighted Average Shares | 72.8M +83.15% | 39.7M +32.31% | 30.0M +27.03% | 23.6M +355.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 36.8M +47.19% | 25.0M -16.42% | 29.9M -28.01% | 41.6M -24.05% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 36.8M +47.19% | 25.0M -16.42% | 29.9M -28.01% | 41.6M -24.05% | |
Total Current Assets | 48.0M +62.38% | 29.6M -13.64% | 34.2M -28.18% | 47.6M -19.23% | |
Accumulated Depreciation | 187,000 -83.82% | 1.2M +10.20% | 1.0M +10.07% | 953,000 +9.54% | |
Property and Plant and Equipment and Net | 93,000 -48.62% | 181,000 -36.27% | 284,000 +21.89% | 233,000 +60.69% | |
Total Long-Term Assets | 93,000 -48.62% | 181,000 -89.55% | 1.7M 0.00% | 1.7M +1,094.48% | |
Total Assets | 48.4M +60.05% | 30.2M -14.02% | 35.2M -30.27% | 50.4M -14.73% | |
Income Taxes Payable | 67,000 -39.09% | 110,000 -25.17% | 147,000 -17.42% | 178,000 +1,269.23% | |
Total Short-Term Debt | 307,000 +10.04% | 279,000 -48.71% | 544,000 -14.20% | 634,000 -46.77% | |
Total Current Liabilities | 13.9M +24.97% | 11.1M +9.57% | 10.2M +30.46% | 7.8M -0.88% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 443,000 -96.55% | |
Total Long-Term Liabilities | 195,000 -42.98% | 342,000 N/A | 0 -100.00% | 1.7M -23.68% | |
Total Liabilities | 14.1M +22.94% | 11.5M +7.44% | 10.7M +5.04% | 10.2M +29.40% | |
Retained Earnings | -198.6M +13.41% | -175.2M +24.06% | -141.2M +22.35% | -115.4M +22.76% | |
Total Stockholders Equity | 34.3M +82.78% | 18.8M -23.39% | 24.5M -39.19% | 40.2M -21.50% | |
Total Shares Outstanding | 88.9M +48.53% | 59.9M +86.08% | 32.2M +10.95% | 29.0M +30.42% | |
Cash Flow | |||||
Cash from Operating Activities | -24.6M -13.65% | -28.5M +77.76% | -16.0M -13.57% | -18.5M +410.41% | |
Capital Expenditures | 4,000 0.00% | 4,000 -97.28% | 147,000 -14.04% | 171,000 +533.33% | |
Cash from Investing Activities | 9,000 +325.00% | -4,000 -97.28% | -147,000 -14.04% | -171,000 +533.33% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 36.6M +55.19% | 23.6M +421.23% | 4.5M -18.48% | 5.5M -89.58% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | 187,866.67% +20.78% | 155,539.29% N/A | |
Return on Assets | -59.75% -42.49% | -103.89% +72.40% | -60.26% +54.28% | -39.06% N/A | |
Return on Equity | -88.60% -43.64% | -157.19% +97.25% | -79.69% +70.42% | -46.76% N/A | |
Revenue Growth | N/A N/A | N/A N/A | 3.57% -96.31% | 96.86% N/A | |
Current Ratio | 3.45 +29.93% | 2.65 -21.18% | 3.37 -44.94% | 6.11 N/A | |
Cash Ratio | 2.64 +17.78% | 2.24 -23.72% | 2.94 -44.81% | 5.33 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.03 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.02 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow